Rosty Raykov - Mar 31, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Stock Option	Award	$0	+175K	+12.43%	$0.00	1.58M	Mar 31, 2023	Common shares	175K	$8.32	Direct	F1, F2
transaction	FENC	Restricted Share Unit	Award	$0	+87.5K	+5.53%	$0.00	1.67M	Mar 31, 2023	Common shares	87.5K	$0.00	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On March 31, 2023, Rostislav Raykov was granted incentive stock options to purchase 175,000 shares of the issuers common shares pursuant to the issuer's 2020 Equity Incentive Plan.
F2	1/3 of the shares subject to this option shall vest immediately and may be exercised as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this option shall be vested.
F3	On March 31, 2023, Rostislav Raykov was awarded restricted share units to receive 87,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F4	1/3 of the shares subject to this award shall be released from restriction as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this award shall be released.